The role of UICC and its members on antimicrobial resistance

The threat of antimicrobial resistance (AMR) and its impact on cancer treatment is a priority for UICC.

Researcher at his desk

Currently, knowledge and awareness of the impact of AMR on cancer outcomes within the cancer community is low.  It is urgent that oncology professionals, cancer advocates, programme managers, patient groups and other stakeholders working in the field of cancer understand and address the factors that contribute to the development and spread of AMR and develop and strategies for infection prevention and control.

In this regard, UICC provides information to increase awareness and supports the cancer community to drive policy change, taking forward the WHO global action plan on antimicrobial resistance adopted by the World Health Assembly in 2015, which outlines the following five objectives:

  1. Improve awareness and understanding of antimicrobial resistance through effective communication, education and training.
  2. Strengthen the knowledge and evidence base through surveillance and research.
  3. Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
  4. Optimise the use of antimicrobial medicines in human and animal health.
  5. Develop the economic case for sustainable investment that takes account of the needs of all countries and to increase investment in new medicines, diagnostic tools, vaccines and other interventions.

UICC leads a task force on AMR and its impact on cancer care outcomes. The task force includes experts from the infectious diseases and cancer communities.

The task force will showcase current evidence, identify research gaps in knowledge of cancer and AMR, share best practices, and ultimately engage the cancer community to collaborate and bring about policy change on addressing the threat of AMR.

UICC is committed to ensuring that AMR remains a priority globally and has highlighted the need to address AMR for better cancer care outcomes at the global health level. At the 74th World Health Assembly, UICC stressed the need for governments, the cancer community and infections diseases communities to unite and raise awareness on AMR, share best practices for the rational use of antimicrobials and mobilize capacity building for R&D for new antimicrobials and diagnostics.

Do you want to increase your knowledge and awareness about AMR?

Sign-up to UICC's self-guided course on addressing the threat of AMR for better cancer care outcomes.

This course is accredited by the Accreditation Council of Oncology in Europe (ACOE). Open to all UICC members.

UICC has been active in raising awareness within the cancer community and beyond on the importance of addressing AMR through communications, including news and blogs, virtual learning activities, virtual dialogues, articles in science journals, and through social media (please see our resources hub for more).

In the coming months, UICC will continue to raise awareness on AMR and highlight the importance of  multisectoral collaboration.  

Virtual Dialogues

Master course: Antimicrobial resistance and its impact on cancer care | UICC

Union for International Cancer Control (UICC)

Special Focus Dialogue: Antimicrobial resistance (AMR) | UICC

Union for International Cancer Control (UICC)

Special Focus Dialogue - Drugs don't work

Union for International Cancer Control (UICC), GARDP

Special Focus Dialogue - Impact of antimicrobial resistance on cancer care outcomes

Union for International Cancer Control (UICC), Wellcome Trust
Antimicrobial resistance

Antimicrobial resistance (AMR) or drug resistance, including antibiotic resistance, is a growing public health issue and needs urgent attention in countries around the world.

hands holding an AMR publication

This page regroups important resources on antimicrobial resistance, material for UICC's members and partners, infographics, videos and other important documents and links.

Last update

Thursday 16 February 2023

Share this page